Health Products
Health Products
| 1 | Notification of the Food and Drug Administration Re: Guidelines for the Registration of Modern Drugs for Human Use and Amendments to the Drug Registration through the Reference of Evaluation Results from the Collaborative Registration Procedure (CRP) |
| 2 | Notification of the Ministry of Public Health Re: Rules, Procedures and Conditions for Modern Drug Distribution, B.E. 2564 (2021)* |
| 3 | Notification of the Food and Drug Administration Re: Guidelines for the Consideration of Low-Risk Medicinal Product Registrations |
| 4 | Ministerial Regulation on Renewal of Drug Formula Registration Certificates, B.E. 2566 (2023)* |
| 5 | Notification of the Food and Drug Administration Re: Guidelines for the Consideration of Applications for Modern Drug Registrations Submitted through Electronic Means (No.2) |
| 6 | Notification of the Food and Drug Administration Re: Guidelines for the Consideration of Applications for Modern Drug Registrations Submitted through Electronic Means |
| 7 | Notification of the Ministry of Public Health Re: Rules, Procedures and Conditions for Herbal Product Importation and Sale, B.E. 2566 (2023)* |
| 8 | Notification of the Ministry of Public Health Re: Type 1, Type 2, Type 4, and Type 5 Narcotic Transit Inspection, B.E. 2567 (2024)* |
| 9 | Ministerial Regulation No. 24 (B.E. 2537 (1994)) Issued under the Drugs Act, B.E. 2510 (1967)* |
| 10 | Notification of the Food and Drug Administration Re: Prescribing the Psychotropic Substance Inspection Form in The Case of Import, Export or Transit |
